Skip to main content

Scarlet Therapeutics

Bristol, United Kingdom

Scarlet Therapeutics is developing the novel red blood cell-based therapeutics (tRBCs) generation platform.

$4.4M raised
May 2026
Seed

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Scarlet Therapeutics

How much funding has Scarlet Therapeutics raised?
Scarlet Therapeutics has raised $4.4M in total funding. The most recent round was Seed. The last funding was announced in May 2026.
Who are Scarlet Therapeutics's investors?
Scarlet Therapeutics's investors include Eos, SCVC, Daft Capital, Oshen, Meltwind Advisory.
Where is Scarlet Therapeutics headquartered?
Scarlet Therapeutics is headquartered in Bristol, United Kingdom.
What does Scarlet Therapeutics do?
Scarlet Therapeutics is developing the novel red blood cell-based therapeutics (tRBCs) generation platform.
What stage is Scarlet Therapeutics at?
Scarlet Therapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Scarlet Therapeutics — Funding & Investors." VCBacked, May 7, 2026, https://www.vcbacked.co/company/scarlet-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2026). Scarlet Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/scarlet-therapeutics
Wikipedia (cite web)
{{cite web |title=Scarlet Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/scarlet-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .